Covered recipient · General Payments record
LATANGELA SMITH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2023
$3,296.41
- Reported across 207 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.95 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $55.67 | 4 |
| JAZZ PHARMACEUTICALS INC. | $31.24 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.40 | 1 |
| Merz Pharmaceuticals, LLC | $20.87 | 1 |
| UCB, Inc. | $18.51 | 1 |
| Sumitomo Pharma America, Inc. | $14.98 | 1 |
| LivaNova USA, Inc. | $14.01 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $15.07 | 02/17/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999053683 | CMS |
| AbbVie Inc. | $13.62 | 03/23/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999053685 | CMS |
| AbbVie Inc. | $12.81 | 04/19/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999053687 | CMS |
| AbbVie Inc. | $14.17 | 05/18/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999053689 | CMS |
| Jazz Pharmaceuticals Inc. | $31.24 | 04/25/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1059092429 | CMS |
| LivaNova USA, Inc. | $14.01 | 01/25/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1042988491 | CMS |
| Merz Pharmaceuticals, LLC | $20.87 | 02/02/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1048314371 | CMS |
| Novartis Pharmaceuticals Corporation | $22.40 | 03/07/2023 | Food and Beverage | Undisputed | 06/30/2026 | 993286807 | CMS |
| Sumitomo Pharma America, Inc. | $14.98 | 04/18/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1030758271 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.27 | 02/23/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1056726823 | CMS |
| UCB, Inc. | $18.51 | 02/16/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1021612269 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.